Unraveling the role of core promoter variation in triple-negative breast cancer: Study
TNBC is a particularly aggressive subtype of breast cancer, characterized by the absence of three key receptors: estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor 2 (HER2). Approximately ...
Jul 25, 2023
0
1